MFS
SUPN icon

Mirabella Financial Services’s Supernus Pharmaceuticals SUPN Stock Holding History

Mirabella Financial Services’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,862
Closed -$242K – 1164
2025
Q4 		$242K Buy
+4,862
New +$236K 0.02% 541
2023
Q2 		– Sell
-6,804
Closed -$247K – 651
2023
Q1 		$247K Buy
+6,804
New +$262K 0.04% 329

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirabella Financial Services's SUPN Position: Q1 2026 in Review

Mirabella Financial Services sold out of Supernus Pharmaceuticals (SUPN) in Q1 2026, closing a stake of 4,862 shares — an estimated $242K sold.

Mirabella Financial Services first reported a position in SUPN in Q1 2023 and held it in 2 quarters. The position peaked at $247K in Q1 2023. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Mirabella Financial Services reported no remaining Supernus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Mirabella Financial Services sold 4,862 Supernus Pharmaceuticals shares in Q1 2026, an estimated $242K.
  • Mirabella Financial Services first reported a position in Supernus Pharmaceuticals in Q1 2023 and held it in 2 quarters.
  • Mirabella Financial Services's Supernus Pharmaceuticals position peaked at $247K in Q1 2023.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Mirabella Financial Services's 13F filing for Q1 2026, filed 12 May 2026.